Rnb Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -153.46%
- Ebitda -133.98%
- Net Worth -39.79%
- Total Assets -58.84%
About Rnb Pharmaceuticals India
Rnb Pharmaceuticals India Private Limited (RPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2018 (Six years and 11 months 20 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hrushikesh Sethy and Pranab Sadhukhan serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52310OR2018PTC028413
-
Company No.
028413
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2018
-
Date of AGM
28 Aug 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Rnb Pharmaceuticals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hrushikesh Sethy
|
Director | 24-Mar-2023 | Current |
|
Pranab Sadhukhan
|
Director | 16-Aug-2024 | Current |
Financial Performance of Rnb Pharmaceuticals India.
Rnb Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 153.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rnb Pharmaceuticals India?
Unlock access to Rnb Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gruhakarigar Private LimitedHrushikesh Sethy is a mutual person
-
Sadhukhan Industries Private Limited
Pranab Sadhukhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rnb Pharmaceuticals India?
Unlock and access historical data on people associated with Rnb Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rnb Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rnb Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
